Cochrane advises against preprints, is highly ineffective, and protects its “brand”
Last year, we updated our Cochrane review on mammography screening with more mortality data and sent it to Cochrane in August 2023. The many comments we received on the very minor, fourth update of a well-known and highly cited Cochrane review that has been around for 23 years1 illustrates that Cochrane has become a highly […]
Cochrane advises against preprints, is highly ineffective, and protects its “brand” Read More »